NCT05919056 Cardiovascular Risk Assessment and Dynamic Monitoring-based Prevention Trial
| NCT ID | NCT05919056 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University |
| Condition | Cardiovascular Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 22,032 participants |
| Start Date | 2023-07-06 |
| Primary Completion | 2028-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 22,032 participants in total. It began in 2023-07-06 with a primary completion date of 2028-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The CRITICALLY study is a cluster randomized trial that will evaluate the effectiveness of a risk-based dynamic monitoring strategy for the primary prevention of cardiovascular high-risk Chinese adults.
Eligibility Criteria
Inclusion Criteria: * Residents in the Yinzhou District have a unique health ID; * Aged 40 to 79 years at the baseline enrollment; * With high risk of cardiovascular disease evaluated by the 2019 WHO laboratory-based risk models (10-year risk≥10%); Exclusion Criteria: * Have a history of coronary heart disease, stroke or heart failure; * Patients with a diagnosis of cancer; * Refused to provide written informed consent
Contact & Investigator
Xun TANG, PhD, MHS
PRINCIPAL INVESTIGATOR
Frequently Asked Questions
Who can join the NCT05919056 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 79 Years, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05919056 currently recruiting?
Yes, NCT05919056 is actively recruiting participants. Contact the research team at tangxun@bjmu.edu.cn for enrollment information.
Where is the NCT05919056 trial being conducted?
This trial is being conducted at Ningbo, China.
Who is sponsoring the NCT05919056 clinical trial?
NCT05919056 is sponsored by Peking University. The principal investigator is Xun TANG, PhD, MHS. The trial plans to enroll 22,032 participants.